US Map / Ohio
State OH

Clinical Trials in Ohio

Ohio is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Ohio and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 474 actively recruiting studies with Ohio sites out of 474 registered in total. The busiest research areas in Ohio are Acute Myeloid Leukemia, Endometrial Cancer, Advanced Solid Tumor. Leading sponsors running trials in the state include Children's Hospital Medical Center, Cincinnati, Ohio State University, The Cleveland Clinic. By stage, Ohio trials break down as Phase 1 (73), Phase 2 (129), Phase 3 (135), Phase 4 (17).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
474
Recruiting Now
474
← Back to US Map
Top Conditions in Ohio
Acute Myeloid Leukemia (8)Endometrial Cancer (7)Advanced Solid Tumor (6)Heart Failure (6)Multiple Myeloma (5)Ovarian Cancer (5)Stroke (5)Breast Cancer (5)Solid Tumor (4)Prostate Cancer (4)Autism Spectrum Disorder (4)Chronic Lymphocytic Leukemia (4)

Frequently Asked Questions — Clinical Trials in Ohio

How many clinical trials are currently recruiting in Ohio?
ClinicalMetric currently tracks 474 actively recruiting clinical trials with at least one location in Ohio. The total number of registered studies—including active but not currently enrolling trials—is 474. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Ohio?
Ohio hosts clinical trials across a broad range of medical conditions, including Acute Myeloid Leukemia, Endometrial Cancer, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Ohio serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Ohio?
To join a clinical trial in Ohio, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Ohio maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Ohio

NCT07200830 Phase 3
Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA ...
Condition
Metastatic Castration-Resistant Prostate Carcinoma
Enrollment
1,524 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
View Trial →
NCT06355336 N/A
Recruiting
Real World Prostate Cancer Registry
Condition
Prostate Cancer
Enrollment
1,000 pts
Location
United States
Sponsor
Cincinnati Cancer Advisors
View Trial →
NCT04317534 Phase 2
Recruiting
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I N...
Condition
NSCLC, Stage I
Enrollment
244 pts
Location
United States
Sponsor
Greg Durm, MD
View Trial →
NCT03981575 N/A
Recruiting
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
Condition
Myotonic Dystrophy 1
Enrollment
700 pts
Location
United States, Canada, Germany
Sponsor
Virginia Commonwealth Universi
View Trial →
NCT05856981 Phase 1
Recruiting
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Condition
Solid Tumor, Adult
Enrollment
130 pts
Location
United States, Belgium, Spain
Sponsor
Sairopa B.V.
View Trial →
NCT05018481 EARLY_Phase 1
Recruiting
HA35 Moderate Alcoholic Hepatitis (AH) Study
Condition
Alcoholic Hepatitis
Enrollment
54 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
NCT03671044 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspens...
Condition
Triple Negative Breast Cancer
Enrollment
657 pts
Location
United States, India
Sponsor
Jina Pharmaceuticals Inc.
View Trial →
NCT07160244 Phase 3
Recruiting
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregn...
Condition
Healthy
Enrollment
6,000 pts
Location
United States, Argentina, Brazil
Sponsor
Pfizer
View Trial →
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06807203 N/A
Recruiting
Motor-voice Assessment in Infants (MAMI)
Condition
Cerebral Palsy Infantile
Enrollment
46 pts
Location
United States
Sponsor
Ohio State University
View Trial →
NCT07165028 Phase 3
Recruiting
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associ...
Condition
Metabolic Dysfunction-Associated Steatotic Liver Disease
Enrollment
4,500 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
View Trial →
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.
View Trial →
NCT02824471 N/A
Recruiting
Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
Condition
Sickle Cell Disease
Enrollment
100 pts
Location
United States
Sponsor
University Hospitals Cleveland
View Trial →
NCT06324201 N/A
Recruiting
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use i...
Condition
Paroxysmal Atrial Fibrillation
Enrollment
250 pts
Location
United States
Sponsor
Heart Rhythm Clinical and Rese
View Trial →
NCT06576271 Phase 1
Recruiting
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE...
Condition
Systemic Lupus Erythematosus
Enrollment
142 pts
Location
United States, Argentina, Brazil
Sponsor
GlaxoSmithKline
View Trial →
NCT04949464 N/A
Recruiting
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoki...
Condition
HIV Infection
Enrollment
100 pts
Location
United States
Sponsor
AIDS Malignancy Consortium
View Trial →
NCT07284472 Phase 2, Phase 3
Recruiting
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzh...
Condition
Agitation Associated With Alzheimer's Disease Dementia
Enrollment
300 pts
Location
United States, Canada, Czechia
Sponsor
Exciva GmbH
View Trial →
NCT03175471 N/A
Recruiting
MRI Based Biomarkers in Pediatric Autoimmune Liver Disease
Condition
Autoimmune Liver Disease
Enrollment
115 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT05915299 N/A
Recruiting
US National OCS Heart Perfusion (OHP) Registry
Condition
Heart Transplant
Enrollment
100,000 pts
Location
United States
Sponsor
TransMedics
View Trial →
NCT04176198 Phase 1, Phase 2
Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Condition
Myelofibrosis
Enrollment
240 pts
Location
United States, Australia, Belgium
Sponsor
Sumitomo Pharma America, Inc.
View Trial →
NCT06129734 Phase 1, Phase 2
Recruiting
Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allo...
Condition
Myeloid Malignancy
Enrollment
20 pts
Location
United States
Sponsor
Benjamin Tomlinson
View Trial →
NCT07099599 N/A
Recruiting
Image Detection of Impaired Microcirculatory Reperfusion
Condition
Ischemic Stroke, Acute
Enrollment
40 pts
Location
United States
Sponsor
University of Cincinnati
View Trial →
NCT07288398 Phase 3
Recruiting
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Condition
Pulmonary Hypertension Associated With HFpEF
Enrollment
540 pts
Location
United States, Argentina, Austria
Sponsor
Tenax Therapeutics, Inc.
View Trial →
NCT05885698 N/A
Recruiting
MYLUNG Consortium Part 3: Observational Study
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
7,500 pts
Location
United States
Sponsor
US Oncology Research
View Trial →
Page 2 of 19 — 474 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology